About 6.7 million American adults are living with heart failure (HF), and prevalence is expected to reach more than 8 million by 2030.
Nogo-A inhibition demonstrates potential for spinal cord injury recovery
The latest study results have been published online in the renowned “The Lancet Neurology” journal. A multi-centre clinical trial (NISCI trial: Nogo-A Inhibition in acute